ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/01/14 | 2,104 | 2,107 | 2,068 | 2,078 | -29 | -1.4% | 58,700 |
2020/01/10 | 2,094 | 2,119 | 2,094 | 2,107 | -1 | ±0% | 44,400 |
2020/01/09 | 2,104 | 2,115 | 2,089 | 2,108 | +37 | +1.8% | 40,900 |
2020/01/08 | 2,073 | 2,087 | 2,042 | 2,071 | -20 | -1% | 59,000 |
2020/01/07 | 2,061 | 2,101 | 2,061 | 2,091 | +55 | +2.7% | 61,000 |
2020/01/06 | 2,011 | 2,056 | 2,011 | 2,036 | -68 | -3.2% | 95,300 |
2019/12/30 | 2,131 | 2,131 | 2,101 | 2,104 | -33 | -1.5% | 46,100 |
2019/12/27 | 2,132 | 2,146 | 2,121 | 2,137 | +18 | +0.8% | 42,200 |
2019/12/26 | 2,111 | 2,121 | 2,088 | 2,119 | +15 | +0.7% | 43,300 |
2019/12/25 | 2,125 | 2,127 | 2,103 | 2,104 | -5 | -0.2% | 36,700 |
2019/12/24 | 2,100 | 2,127 | 2,100 | 2,109 | +23 | +1.1% | 41,500 |
2019/12/23 | 2,082 | 2,100 | 2,077 | 2,086 | +8 | +0.4% | 36,800 |
2019/12/20 | 2,098 | 2,105 | 2,073 | 2,078 | -27 | -1.3% | 77,900 |
2019/12/19 | 2,073 | 2,107 | 2,069 | 2,105 | +23 | +1.1% | 50,100 |
2019/12/18 | 2,122 | 2,122 | 2,074 | 2,082 | -34 | -1.6% | 58,700 |
2019/12/17 | 2,119 | 2,120 | 2,095 | 2,116 | +2 | +0.1% | 67,700 |
2019/12/16 | 2,124 | 2,124 | 2,109 | 2,114 | -9 | -0.4% | 34,500 |
2019/12/13 | 2,123 | 2,143 | 2,114 | 2,123 | +35 | +1.7% | 80,000 |
2019/12/12 | 2,100 | 2,115 | 2,088 | 2,088 | -36 | -1.7% | 51,700 |
2019/12/11 | 2,157 | 2,157 | 2,117 | 2,124 | -26 | -1.2% | 40,100 |
2019/12/10 | 2,182 | 2,190 | 2,147 | 2,150 | -22 | -1% | 41,100 |
2019/12/09 | 2,155 | 2,175 | 2,143 | 2,172 | +17 | +0.8% | 63,500 |
2019/12/06 | 2,144 | 2,165 | 2,140 | 2,155 | -17 | -0.8% | 47,500 |
2019/12/05 | 2,170 | 2,188 | 2,145 | 2,172 | +2 | +0.1% | 73,200 |
2019/12/04 | 2,092 | 2,178 | 2,083 | 2,170 | +66 | +3.1% | 108,400 |
2019/12/03 | 2,152 | 2,157 | 2,029 | 2,104 | -74 | -3.4% | 185,900 |
2019/12/02 | 2,160 | 2,183 | 2,160 | 2,178 | +18 | +0.8% | 49,500 |
2019/11/29 | 2,163 | 2,174 | 2,146 | 2,160 | +9 | +0.4% | 64,300 |
2019/11/28 | 2,166 | 2,166 | 2,130 | 2,151 | -7 | -0.3% | 66,700 |
2019/11/27 | 2,144 | 2,176 | 2,140 | 2,158 | +31 | +1.5% | 67,700 |
2019/11/26 | 2,187 | 2,188 | 2,124 | 2,127 | -33 | -1.5% | 94,200 |
2019/11/25 | 2,148 | 2,169 | 2,144 | 2,160 | +29 | +1.4% | 58,300 |
2019/11/22 | 2,144 | 2,146 | 2,123 | 2,131 | +6 | +0.3% | 47,700 |
2019/11/21 | 2,130 | 2,137 | 2,091 | 2,125 | +10 | +0.5% | 52,000 |
2019/11/20 | 2,110 | 2,124 | 2,093 | 2,115 | +25 | +1.2% | 28,900 |
2019/11/19 | 2,064 | 2,102 | 2,064 | 2,090 | +13 | +0.6% | 40,500 |
2019/11/18 | 2,071 | 2,090 | 2,055 | 2,077 | -3 | -0.1% | 43,400 |
2019/11/15 | 2,073 | 2,094 | 2,072 | 2,080 | +23 | +1.1% | 44,700 |
2019/11/14 | 2,070 | 2,088 | 2,042 | 2,057 | -19 | -0.9% | 49,400 |
2019/11/13 | 2,113 | 2,124 | 2,076 | 2,076 | -34 | -1.6% | 144,600 |
2019/11/12 | 2,137 | 2,137 | 2,109 | 2,110 | -29 | -1.4% | 73,800 |
2019/11/11 | 2,132 | 2,146 | 2,121 | 2,139 | +7 | +0.3% | 61,000 |
2019/11/08 | 2,140 | 2,140 | 2,094 | 2,132 | +8 | +0.4% | 122,200 |
2019/11/07 | 2,139 | 2,139 | 2,102 | 2,124 | +18 | +0.9% | 75,200 |
2019/11/06 | 2,100 | 2,113 | 2,065 | 2,106 | -1 | ±0% | 78,300 |
2019/11/05 | 2,060 | 2,129 | 2,030 | 2,107 | +70 | +3.4% | 150,300 |
2019/11/01 | 2,060 | 2,071 | 2,027 | 2,037 | -13 | -0.6% | 63,000 |
2019/10/31 | 2,040 | 2,058 | 2,034 | 2,050 | +5 | +0.2% | 70,200 |
2019/10/30 | 2,014 | 2,050 | 2,000 | 2,045 | +25 | +1.2% | 184,300 |
2019/10/29 | 2,015 | 2,022 | 2,002 | 2,020 | +29 | +1.5% | 87,200 |
1301~
1350
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 214,900円 | +3.1% | -6.5% | 2.23% | 9.97倍 | 1.06倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
東和薬品 | 258,800円 | +13.9% | +6.6% | 2.70% | 6.74倍 | 0.80倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 235,900円 | +21.7% | +999.9% | 0.00% | 9.82倍 | 3.25倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 306,000円 | +3.0% | +27.5% | 2.61% | 19.37倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 146,300円 | +8.8% | +99.9% | 3.55% | 9.34倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム